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Inhibition of hormone-induced Ca2+ release from intrac-
ellular stores by cGMP involves a protein complex which
consists of at least 3 proteins, i.e. the inositol-1,3,4-phos-
phat receptor (IP3R), the cGMP-dependent protein kinase
(cGK), and, as a linker protein between both, the inositol-
1,3,4-phosphat receptor associated G-kinase substrate
(IRAG [1]). Recently, mutant mice were created which
lack the part of the IRAG protein that is supposed to medi-
ate the association between IRAG and the IP3R. In these
mice (IRAG∆12 mice), cGMP failed to attenuate both, hor-
mone-induced Ca2+ signals and hormone-induced con-
tractions in vascular preparations [2]. These result confirm
the concept that IRAG is an essential mediator of relaxa-
tion mediated by cGMP/cGK signalling in vascular
smooth muscle.
In the present study, we tested this hypothesis in two
other smooth muscle types, i.e. from jejunum and colon.
In line with the concept above, cGMP failed to relax hor-
mone-induced contractions in colon muscle from
IRAG∆12 mice. In contrast, cGMP clearly relaxed hormone-
induced contractions in jejunum muscle from these
mutant mice. Thus, Rho/Rho kinase rather than IRAG
seems to be the key player in mediating cGMP/cGK signal-
ling in this particular type of smooth muscle.
Next, we questioned whether the mutation of IRAG affects
the relaxant effects of cGMP on hormone-independent
contractions. For this purpose, muscles were contracted by
activation of Ca2+ influx, either by depolarisation with
high K+ or by initiating capacitative Ca2+ entry with thap-
sigargin. Since IRAG is mainly associated with sarcoplas-
matic membrane proteins, we expected that the IRAG
mutation would not affect cell membrane Ca2+ signalling.
Surprisingly, the relaxant effects of cGMP on these types of
contraction were attenuated in intestinal muscles from
IRAG∆12 mice.
The results suggests that (1) the association of IRAG/IP3R
determines cGMP/cGK-mediated relaxations only in dis-
tinct types of smooth muscle, and (2) IRAG participates in
cGMP/cGK-mediated relaxation not only during hor-
mone-induced Ca2+ release but also during hormone-
independent Ca2+ entry. Thus, cGMP/cGK may target via
IRAG, either alone or with the IP3R, to, at present, uniden-
tified elements of the Ca2+ entry machinery in certain
types of smooth muscle.
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